Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Organon & Co. (OGN : NYSE)
 
 • Company Description   
Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J.

Number of Employees: 9,300

 
 • Price / Volume Information   
Yesterday's Closing Price: $38.10 Daily Weekly Monthly
20 Day Moving Average: 1,795,747 shares
Shares Outstanding: 253.64 (millions)
Market Capitalization: $9,663.58 (millions)
Beta:
52 Week High: $39.47
52 Week Low: $27.25
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 17.52% 23.58%
12 Week -3.20% 6.72%
Year To Date 25.12% 49.89%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
30 Hudson Street FL 33
-
Jersey City,NJ 07302
USA
ph: 551-430-6900
fax: -
investor_relations@organon.com http://www.organon.com
 
 • General Corporate Information   
Officers
Kevin Ali - Chief Executive Officer
Carrie Cox - Chairman of the Board of Directors
Matthew Walsh - Chief Financial Officer
Kathryn DiMarco - SVP Finance - Corporate Controller
Robert Essner - Director

Peer Information
Organon & Co. (CHCR)
Organon & Co. (ESRX)
Organon & Co. (MYDP)
Organon & Co. (GBCS)
Organon & Co. (LAXAF)
Organon & Co. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 68622V106
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 253.64
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $9,663.58 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 2.94%
Current Fiscal Quarter EPS Consensus Estimate: $1.28 Indicated Annual Dividend: $1.12
Current Fiscal Year EPS Consensus Estimate: $5.34 Payout Ratio: 0.17
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 05/13/2022 - $0.56
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 7.14
Trailing 12 Months: 5.94
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: 5.20
Price / Sales: 1.52
EPS Growth
vs. Year Ago Period: 5.77%
vs. Previous Quarter: 20.44%
Sales Growth
vs. Year Ago Period: 4.05%
vs. Previous Quarter: -2.31%
ROE
03/31/22 - -103.33
12/31/21 - -1,899.41
09/30/21 - 98.08
ROA
03/31/22 - 14.98
12/31/21 - 15.08
09/30/21 - 15.55
Current Ratio
03/31/22 - 1.61
12/31/21 - 1.45
09/30/21 - 1.38
Quick Ratio
03/31/22 - 1.20
12/31/21 - 1.10
09/30/21 - 1.09
Operating Margin
03/31/22 - 25.60
12/31/21 - 25.46
09/30/21 - 25.85
Net Margin
03/31/22 - 20.42
12/31/21 - 21.43
09/30/21 - 24.03
Pre-Tax Margin
03/31/22 - 23.63
12/31/21 - 24.25
09/30/21 - 28.79
Book Value
03/31/22 - -4.93
12/31/21 - -5.95
09/30/21 - -6.38
Inventory Turnover
03/31/22 - 2.58
12/31/21 - 2.63
09/30/21 - 2.61
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©